13. Termination of Study. 
Primary or secondary graft failure. Two instances of primary graft failure or 1 instance 
of secondary graft failure will terminate the study. 
This study will be also be terminated if 10 consecutive patients achieve prompt and 
durable engraftment. At that point morbidity and expense of the use of PBSC’s vs marrow will be 
determined. Comparisons will as be made with historical control patients as outlined above. We 
expect to accrue 5-6 patients per year into this study. 
14. References. 
1. Cavins JA, Scheer SC, Thomas ED, Ferrebee JW. The recovery of lethally irradiated dogs given 
infusions of autologous leukocytes preserved at -80 C. Blood 23:38-43, 1964. 
2. Storb R, Epstein RB, Thomas ED. Marrow repopulating ability of peripheral blood cells 
compared to thoracic duct cells. Blood 32: 662-667, 1968. 
3. Storb R, Buckner CD, Epstein RB, Graham T, Thomas ED. Clinical and hematologic effects of 
cross circulation in baboons. Transfusion 9:23-31, 1969. 
4. Storb R, Epstein RB, Ragde H, Thomas ED. Marrow engraftment by allogeneic leukocytes in 
lethally irradiated dogs. Blood 30: 805-811, 1967. 
5. Epstein RB, Graham TC, Buckner CD, Thomas ED. Allogeneic marrow engraftment by cross 
circulation in lethally irradiated dogs. Blood 28:692-707, 1966. 
6. Appelbaum ER. Hemopoietic reconstitution following autologous bone marrow and peripheral 
blood mononuclear cell infusions. Exp Hematol 7:7-11, 1979. 
7. Zander AR, Gray KN, Hester JP, Johnston DA, Spitzer G, Raulston GL, McCredie KB, Jardine 
JH, Wu J, Gleiser C, Cardiff J, Dicke KA. Rescue by peripheral blood mononuclear cells in 
dogs from bone marrow failure after total-body-irradiation. Transfusion 24:42-45, 1984. 
8. Fliedner TM. Collection, cryopreservation and transplantation of blood stem cells in the 
treatment of hematopoietic failure. In: Immunology of Bone Marrow Transplantation. 
Thierfelder S, Rodt H, Kolb HJ (eds). Berlin: Springer-Verlag, 1980, pp 53-60. 
9. Korbling M, Fliedner TM, Cavalo W et al: Albumin density gradient purification of canine 
hemopoietic blood stem cells (HBSC): Long-term allogeneic engraftment without GVH reaction. 
Exp Hematol 7:277-288, 1979.7. 
10. Appelbaum FR, Deeg HJ, Storb R, Graham TC, Charrier K, Bensinger W. Cure of malignant 
lymphoma in dogs with peripheral blood stem cell transplantation. Transplantation 42:19-22, 
1986. 
11. McCredie KB, Hersh EM, Freireich EJ. Cells capable of colony formation in the peripheral 
blood of man. Science 171:293-294, 1971. 
12. Zander AR and Cockerill KJ. Autologous transplantation with circulating hemopoietic stem 
cells. J Clin Apheresis 3:191-201, 1987. 
13. Kessinger A, Armitage JO, Smith DM, Landmark JD, Bierman PJ, Weisenburger DD. High- 
dose therapy and autologous peripheral blood stem cell transplantation for patients with 
lymphoma. Blood 74:1260-1265, 1989. 
14. Kessenger A, Bierman PJ, Vose JM, Armitage JO. High-Dose cyclophosphamide, carmustine and 
etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed 
Hodgkin’s disease. Blood 77:2322-2325, 1991. 
15. Bell AJ, Figes A, Oscier DG, Hamblin TJ. Peripheral blood stem cell autografts in the treatment 
of lymphoid malignancies: initial experience in three patients. Br J Haematol 66:63-68, 1987. 
[370] 
Recombinant DNA Research, Volume 16 
